ArticlePakistan journal of medical sciences2025
Effectiveness of transcutaneous tibial nerve stimulation on overactive bladder treatment.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Randomized, Sham-Controlled, Double-Blind Trial of the Intibia System in Urge Urinary Incontinence: Quality-of-Life Outcomes.International urogynecology journal · 2026Article
- Effectiveness of Electric Muscle Stimulation (EMS) and Transcutaneous Electric Nerve Stimulation (TENS) in patients with overactive bladder: A randomized controlled trial.Pakistan journal of medical sciences · 2025Article
- Finite Element Analysis of Von Mises Stress in External Fixators for Open Tibial Fractures: A Comparative Study of ASTM F1541-02 and Tibia-Based Models in Indonesian Patients.Healthcare technology lettersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: There is no consensus on the effectiveness, the sites of application and, optimal dosage and frequency of attendance of transcutaneous tibial nerve stimulation (tTNS) on the treatment of overactive bladder. The aim of the study was to evaluate the long-term effectiveness of eight weeks lasting transcutaneous tibial nerve stimulation (TNS) treatment and its effects on the quality of life of the patients. Method: In this cross-sectional study conducted between September 2022 and December 2023 at a tertiary care center, 56 patients with overactive bladder were allocated to receive transcutaneous tibial nerve stimulation or sham therapy weekly for eight weeks; 30 of them had transcutaneous tibial nerve stimulation (study group) and remaining 26 patients formed the control group. Overactive Bladder Questionnaire Awareness tool V8 (OAB-v8), International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), and Visual Analog scale (VAS) scales were used for evaluation of bothersome degree. Patients who received tTNS therapy have been evaluated at 3rd and 6th and 12th months and time-dependent change in the Incontinence Quality of Life Questionnaire (I-QOL) scores were determined. Results: After eight weeks of tibial nerve stimulation treatment, a statistically significant increase was found in the OAB -V8, ICI-Q and VAS scores compared to the sham therapy group (p<0,05). Minimum 50% increase was achieved in I-QOL scores at the 3rd and 6th months of treatment, but the improvement was less than 50% at the12th month. Conclusions: Transcutaneous TNS is an effective treatment option for women with OAB, but its long-term effectiveness is insufficient. Therefore, rescue sessions to be held at 6-8 month intervals can be used to increase patient satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.